Parkinson’s Disease (PD) is a progressive neurodegenerative disease that causes neurons…
Discovering effective and safe new drugs depends on a detailed knowledge…
The common marmoset, Callithrix jaccus, possesses complex social behaviors and sleep…
In the April 27th issue of JAMA Neurology, researchers released new data that…
According to a study published in Alzheimer’s & Dementia, cognitive decline…
Researchers have designed an antibody that can identify toxic particles that…
RNA sequencing studies of thousands of post mortem human brain samples…
Proteins — large molecules made up of amino acids — do…
Alzheimer’s Disease (AD), a progressive neurodegenerative disease, is estimated to affect…
Last month, American pharmaceutical company Eli Lilly ended its fourth study investigating…
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
Webinars
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.
QPS and Bioanalysis Zone: Advancing Bioanalytical Method Development and Validation for Small Molecules in a Changing Regulatory Landscape
Click here to watch the webinar.

Brain Iron Deposits as a Predictive Measure of Dementia in Parkinson’s Disease
January 4, 2021
Parkinson’s Disease (PD) is a progressive neurodegenerative disease that causes neurons in the area of the brain that controls movement to weaken or die. Up

Advances in Drug Discovery for Central Nervous System Diseases
December 7, 2020
Discovering effective and safe new drugs depends on a detailed knowledge of disease mechanisms, as well as a successful progression from candidate identification to clinical

Marmosets as Primate Models of Familial Alzheimer’s Disease
September 28, 2020
The common marmoset, Callithrix jaccus, possesses complex social behaviors and sleep patterns that closely resemble those of humans. This South American monkey’s metabolism, immune systems,

Flortaucipir PET Shows Promise in Alzheimer’s Disease Diagnosis
July 1, 2020
In the April 27th issue of JAMA Neurology, researchers released new data that suggests 18F-flortaucipir positron emission topography (PET) can help clinicians diagnose late-stage Alzheimer’s Disease (AD).

Repetitive Negative Thinking Linked to Alzheimer’s Disease
June 29, 2020
According to a study published in Alzheimer’s & Dementia, cognitive decline and the deposition of harmful proteins in the brain linked to Alzheimer’s Disease (AD)

Research Breakthrough: Antibodies for the Quantification of Amyloid Beta Oligomers in Alzheimer’s Disease
June 22, 2020
Researchers have designed an antibody that can identify toxic particles that destroy healthy brain cells. A collaboration of scientists from the University of Cambridge, University

Proteomic Analysis Studies in Alzheimer’s Disease and Cerebral Atherosclerosis Research
June 15, 2020
RNA sequencing studies of thousands of post mortem human brain samples have generated massive datasets for use in medical research. These studies implicate many different

Protein Shapes in Alzheimer’s Disease Research
June 8, 2020
Proteins — large molecules made up of amino acids — do most of the work in cells and are required for the structure, function, and

Early Detection of Alzheimer’s Disease Through exRNA Biomarkers
June 1, 2020
Alzheimer’s Disease (AD), a progressive neurodegenerative disease, is estimated to affect around 50 million people worldwide. AD is most prevalent in North America and Western

Solanezumab Study Misses the Mark for the Fourth Time
March 17, 2020
Last month, American pharmaceutical company Eli Lilly ended its fourth study investigating the effectiveness of solanezumab, a potential drug therapy for people with mild cognitive impairment
Executive Summary Biosimilars have advanced from a promising idea to a proven pathway for expanding patient access to biologic therapies and easing pressure on…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
NEWARK, Del.–(BUSINESS WIRE)–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…